Sustained suppression of IL-18 by employing a vaccine ameliorates intestinal inflammation in TNBS-induced murine colitis.

Guan, Qingdong; Warrington, Richard; Moreno, Sem; Qing, Gefei; Weiss, Carolyn; Peng, Zhikang

Guan, Qingdong; Warrington, Richard; Moreno, Sem; Qing, Gefei; Weiss, Carolyn; Peng, Zhikang.

Afiliação

Guan Q; Department of Immunology, University of Manitoba, Winnipeg R3E 3P4, Canada.
Warrington R; Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, R3E 3P4, Canada.
Moreno S; Department of Internal Medicine, University of Manitoba, Winnipeg, R3E 3P4, Canada.
Qing G; Cellular Therapy Laboratory, CancerCare Manitoba, Winnipeg, R3A 1R9, Canada.
Weiss C; Department of Immunology, University of Manitoba, Winnipeg R3E 3P4, Canada.
Peng Z; Department of Internal Medicine, University of Manitoba, Winnipeg, R3E 3P4, Canada.

Future Sci OA ; 5(7): FSO405, 2019 Jul 30.

Article em En | MEDLINE | ID: mdl-31428451

Palavras-chave

IL-18; immunotherapy; murine colitis; peptide-based vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Future Sci OA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google